Effects of deoxyfrenolicin on isolated adipose cells. I. Glucose and fructose utilization.
D000273:Adipose Tissue / Q000187:drug effects* / Q000378:metabolism; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001412:Bacillus subtilis; D002245:Carbon Dioxide / Q000096:biosynthesis; D002247:Carbon Isotopes; D002918:Chymotrypsin / Q000494:pharmacology; D005632:Fructose / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism*; D006601:Hexoses / Q000378:metabolism; D007328:Insulin / Q000494:pharmacology; D008297:Male; D003012:Microbial Collagenase / Q000378:metabolism; D009285:Naphthoquinones / Q000008:administration & dosage / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology; D010084:Oxidation-Reduction; D010447:Peptide Hydrolases / Q000494:pharmacology; D011691:Puromycin / Q000494:pharmacology; D051381:Rats
D000900:Anti-Bacterial Agents; D002247:Carbon Isotopes; D006601:Hexoses; D007328:Insulin; D009285:Naphthoquinones; D002245:Carbon Dioxide; D005632:Fructose; D011691:Puromycin; D010447:Peptide Hydrolases; D002918:Chymotrypsin; D003012:Microbial Collagenase; D005947:Glucose; D009638:Norepinephrine